WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Bioscience Neurolucida
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
The Journal of Neuroscience, December 1, 2004, 24(48):10993-10998; doi:10.1523/JNEUROSCI.2993-04.2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coulom, H.
Right arrow Articles by Birman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coulom, H.
Right arrow Articles by Birman, S.

 Previous Article

BRIEF COMMUNICATION
Chronic Exposure to Rotenone Models Sporadic Parkinson's Disease in Drosophila melanogaster

Hélène Coulom and Serge Birman

Laboratoire de Génétique et Physiologie du Développement, Centre National de la Recherche Scientifique, UniversitédelaMéditerranée, Developmental Biology Institute of Marseille, Campus de Luminy, F-13288 Marseille Cedex 9, France

Parkinson's disease (PD) is a movement disorder characterized by the selective degeneration of nigrostriatal dopaminergic neurons. Both familial and sporadic cases present tremor, rigidity, slowness of movement, and postural instability. Although major insights into the genes responsible for some rare hereditary cases have arisen, the etiology of sporadic cases remains unknown. Epidemiological studies have suggested an association with environmental toxins, mainly mitochondrial complex I inhibitors such as the widely used pesticide rotenone. In recent years, Drosophila melanogaster has been used as a model of several neurodegenerative diseases, including a genetic model of PD. Here, we studied the neurodegenerative and behavioral effects of a sublethal chronic exposure to rotenone in Drosophila. After several days, the treated flies presented characteristic locomotor impairments that increased with the dose of rotenone. Immunocytochemistry analysis demonstrated a dramatic and selective loss of dopaminergic neurons in all of the brain clusters. The addition of L-dopa (3,4-dihydroxy-L-phenylalanine) into the feeding medium rescued the behavioral deficits but not neuronal death, as is the case in human PD patients. In contrast, the antioxidant melatonin (N-acetyl-5-methoxytryptamine) alleviated both symptomatic impairment and neuronal loss, supporting the idea that this agent may be beneficial in the treatment of PD. Therefore, chronic exposure to pesticides recapitulates key aspects of PD in Drosophila and provides a new in vivo model for studying the mechanisms of dopaminergic neurodegeneration.

Key words: dopamine; rotenone; melatonin; neurodegeneration; Drosophila melanogaster; Parkinson's disease

Received July 22, 2004; revised October 12, 2004; accepted October 17, 2004.




This article has been cited by other articles:


Home page
 GeneticsHome page
J. Z. Morris, L. Bergman, A. Kruyer, M. Gertsberg, A. Guigova, R. Arias, and M. Pogorzelska
Mutations in the Drosophila Mitochondrial tRNA Amidotransferase, bene/gatA, Cause Growth Defects in Mitotic and Endoreplicating Tissues
Genetics, February 1, 2008; 178(2): 979 - 987.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. Wassef, R. Haenold, A. Hansel, N. Brot, S. H. Heinemann, and T. Hoshi
Methionine Sulfoxide Reductase A and a Dietary Supplement S-Methyl-L-Cysteine Prevent Parkinson's-Like Symptoms
J. Neurosci., November 21, 2007; 27(47): 12808 - 12816.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. Wang, R. Lu, X. Ouyang, M. W. L. Ho, W. Chia, F. Yu, and K.-L. Lim
Drosophila Overexpressing Parkin R275W Mutant Exhibits Dopaminergic Neuron Degeneration and Mitochondrial Abnormalities
J. Neurosci., August 8, 2007; 27(32): 8563 - 8570.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
T.-K. Sang, H.-Y. Chang, G. M. Lawless, A. Ratnaparkhi, L. Mee, L. C. Ackerson, N. T. Maidment, D. E. Krantz, and G. R. Jackson
A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine
J. Neurosci., January 31, 2007; 27(5): 981 - 992.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Wang, L. Qian, H. Xiong, J. Liu, W. S. Neckameyer, S. Oldham, K. Xia, J. Wang, R. Bodmer, and Z. Zhang
From the Cover: Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila
PNAS, September 5, 2006; 103(36): 13520 - 13525.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S.-L. Hsuan, H. M. Klintworth, and Z. Xia
Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways.
J. Neurosci., April 26, 2006; 26(17): 4481 - 4491.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
A. M. Celotto and M. J. Palladino
Drosophila: A "Model" Model System To Study Neurodegeneration
Mol. Interv., October 1, 2005; 5(5): 292 - 303.
[Abstract] [Full Text] [PDF]


-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-